Search

You searched for "Oculus"

1301 results found

From Moorfields to Mombasa: The tale of two ophthalmology electives

1 April 2026 | | EYE - General
Ophthalmology fascinates me because the field uniquely combines microsurgical precision with immediate, life-changing outcomes, spanning nine distinct subspecialties that seamlessly integrate medicine, surgery and cutting-edge technology. Put simply, few single organs can match the breadth and depth of pathology the...

In conversation with Fares Antaki: The retinal age gap in schizophrenia

3 April 2026 | | EYE - Vitreo-Retinal
Fares Antaki. Nima Ghadiri (NG): The ‘retinal age gap’ (RAG) is a relatively new concept. Based on your study [1], how confident are you in proposing this as a non-invasive, accessible biomarker for accelerated biological ageing in patients with neuropsychiatric...

RCOphth Annual Congress 2026

18 May 2026 -21 May 2026
The Royal College of Ophthalmologists (RCOphth) Annual Congress 2026

What's trending Jun/Jul 2026

3 June 2026 | | EYE - General
A round-up of the eye related hot topics that have been trending on social media over the last few weeks. #Volleyball #EyeInjury Multiple outlets have picked up the story of Lee Cuthbert, who was on holiday in Mexico and playing...

The paediatric cataract: an overview of the diagnosis and management

5 August 2020 | | EYE - Cataract, EYE - Refractive, EYE - General
In this second article (see first article here), Samuel Aryee and Rhys Dumont Jones review the challenges involved in managing this condition. Examination and diagnosis Cataracts in children can appear in a variety of forms, each presenting in a different...

An update on inherited retinal disorders (part 2): Approaches to therapy for IRDs

1 December 2016 | | EYE - Vitreo-Retinal
Part 1 of this topic can be found here There are currently no proven cures for inherited retinal disease (IRD). However, multiple avenues of research are being investigated to better understand disease mechanisms and trial potential therapies that may slow...

A closer look at the new wave of glaucoma surgery – radical or old school?

1 October 2016 | | EYE - Glaucoma
Glaucoma is a challenging condition to treat because the exact pathophysiology remains unclear and the only readily modifiable factor is the intraocular pressure (IOP). Additionally, most glaucoma patients are completely asymptomatic, yet are often subjected to lifelong medical therapy. The...

The role of inflammation in the pathophysiology of DMO

1 February 2016 | | EYE - Vitreo-Retinal
Diabetic macular oedema (DMO) is a major cause of visual loss in diabetes, with a complex multifactorial pathogenesis. In the UK alone it is estimated that there are nearly 2.5 million diabetic patients aged over 12 years. Approximately 65,000 of...

Childhood glaucoma

2 October 2025 | | EYE - Paediatrics, EYE - Glaucoma
When a child is given a diagnosis of glaucoma, the impact upon that child and their family is enormous; equivalent to the diagnosis of a cancer [14]. This previously published article (2019) outlines the knowledge, techniques and approaches that offer...

Coming to terms with AI

1 August 2019 | | EYE - Imaging, EYE - Vitreo-Retinal, EYE - Glaucoma, EYE - General
A machine might be called intelligent if its response to questions could convince a person that it was human, a test proposed by Alan Turing in 1950 [1]. The author considers potential applications of artificial intelligence (AI) using machine learning...

Effect of the COVID-19 Urgent Eyecare Service on patient referrals to general practitioners and Hospital Eye Service

28 April 2023 | | EYE - General
The COVID-19 Urgent Eyecare Services (CUES) was developed to relieve the demands of hospital ophthalmology, aiming to allow patients to have remote consultations and be managed by community optometric practice. This was because access to Hospital Eye Service (HES) Ophthalmic...

RCOphth Annual Congress 2022 - Preview

19 May 2022
Eye News previews the RCOphth Annual Congress 2022, as we look forward to the return of an in-person Congress for the first time since 2019. Follow updates and key events here.